Patent · US Active

Targeted integration into the PPP1R12C locus

US8110379B2 · kind B2 · utility

86Cited by

15References

26Claims

0Family size

Assignee

Sangamo Biosciences, Inc. · US

Inventors

Russell DeKelver · Daly City, US
Philip D. Gregory · Richmond, US
David Paschon · Oakland, US
Phillip Tam · Walnut, US
Fyodor Urnov · Richmond, US

Key dates

Filing date	Apr 24, 2008
Grant date	Feb 7, 2012
Priority date	—
Expiry date	Aug 16, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2800/30
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Disclosed herein are methods and compositions for targeted integration of an exogenous sequence into the human PPP1R12C locus, for example, for expression of a polypeptide of interest.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.